Skip to content
10-Q

Quarterly Report

ACER THERAPEUTICS INC.

0000950170-23-065159

← back to feed
Filed
Nov 20, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 8, 2023 24.46M sh
Shares Diluted Q3 2023 · Sep 30, 2023 24.46M sh
Shares Diluted Q3 2023 · Sep 30, 2023 23.25M sh
Shares Diluted Q3 2023 · Sep 30, 2022 16.09M sh
Shares Diluted Q3 2023 · Sep 30, 2022 17.09M sh
Capex Q3 2023 · Sep 30, 2023 $3.07K
Capex Q3 2023 · Sep 30, 2022 $35.84K
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$28.9M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$21.95M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $594.66K
Cash And Equivalents Q3 2023 · Dec 31, 2022 $2.33M
Stockholders Equity Q3 2023 · Sep 30, 2023 −$47.74M
Stockholders Equity Q3 2023 · Jun 30, 2023 −$33.25M
Stockholders Equity Q3 2023 · Mar 31, 2023 −$26.11M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$16.76M
Stockholders Equity Q3 2023 · Sep 30, 2022 −$12.21M
Stockholders Equity Q3 2023 · Jun 30, 2022 −$8.78M
Stockholders Equity Q3 2023 · Mar 31, 2022 −$10.1M
Stockholders Equity Q3 2023 · Dec 31, 2021 −$1.72M
Current Liabilities Q3 2023 · Sep 30, 2023 $61.67M
Current Liabilities Q3 2023 · Dec 31, 2022 $18.95M
Total Liabilities Q3 2023 · Sep 30, 2023 $61.75M
Total Liabilities Q3 2023 · Dec 31, 2022 $28.39M
Current Assets Q3 2023 · Sep 30, 2023 $6.14M
Current Assets Q3 2023 · Dec 31, 2022 $3.52M
Total Assets Q3 2023 · Sep 30, 2023 $14M
Total Assets Q3 2023 · Dec 31, 2022 $11.62M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.60
Eps Diluted Q3 2023 · Sep 30, 2023 −$1.68
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.31
Eps Diluted Q3 2023 · Sep 30, 2022 −$1.13
Eps Basic Q3 2023 · Sep 30, 2023 −$0.60
Eps Basic Q3 2023 · Sep 30, 2023 −$1.68
Eps Basic Q3 2023 · Sep 30, 2022 −$0.31
Eps Basic Q3 2023 · Sep 30, 2022 −$1.11
Sga Expense Q3 2023 · Sep 30, 2023 $4.69M
Sga Expense Q3 2023 · Sep 30, 2023 $10.11M
Sga Expense Q3 2023 · Sep 30, 2022 $2.56M
Sga Expense Q3 2023 · Sep 30, 2022 $10.07M
Rd Expense Q3 2023 · Sep 30, 2023 $1.52M
Rd Expense Q3 2023 · Sep 30, 2023 $5.38M
Rd Expense Q3 2023 · Sep 30, 2022 $2.68M
Rd Expense Q3 2023 · Sep 30, 2022 $9.28M
Net Income Q3 2023 · Sep 30, 2023 −$14.73M
Net Income Q3 2023 · Sep 30, 2023 −$39.1M
Net Income Q3 2023 · Jun 30, 2023 −$8.09M
Net Income Q3 2023 · Mar 31, 2023 −$16.28M
Net Income Q3 2023 · Sep 30, 2022 −$5.01M
Net Income Q3 2023 · Sep 30, 2022 −$16.85M
Net Income Q3 2023 · Jun 30, 2022 −$2.67M
Net Income Q3 2023 · Mar 31, 2022 −$9.18M
Operating Income Q3 2023 · Sep 30, 2023 −$12.88M
Operating Income Q3 2023 · Sep 30, 2023 −$22.16M
Operating Income Q3 2023 · Sep 30, 2022 −$5.24M
Operating Income Q3 2023 · Sep 30, 2022 −$19.35M
Cost Of Revenue Q3 2023 · Sep 30, 2023 $83.81K
Cost Of Revenue Q3 2023 · Sep 30, 2023 $83.81K
Revenue Q3 2023 · Sep 30, 2023 $371.79K
Revenue Q3 2023 · Sep 30, 2023 $371.79K